NICOLE MARTINEZ: Open Payments
NPI 1013753383 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$773 in 32 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $223 · 2025 $773
Food & beverage: $773
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 2 | $130 |
| PFIZER INC. | 5 | $90 |
| JAZZ PHARMACEUTICALS INC. | 2 | $62 |
| Janssen Biotech, Inc. | 3 | $59 |
| KYOWA KIRIN, INC. | 2 | $47 |
| Incyte Corporation | 2 | $46 |
| Daiichi Sankyo Inc. | 2 | $44 |
| Regeneron Healthcare Solutions, Inc. | 2 | $41 |
| Karyopharm Therapeutics Inc. | 2 | $38 |
| Lilly USA, LLC | 2 | $37 |
Products named: SARCLISA, ELREXFIO, RYLAZE, POTELIGEO, MONJUVI, Vanflyta, LYNOZYFIC, CARVYKTI.
Industry payments across CO — which companies pay providers there.
